256 related articles for article (PubMed ID: 24002086)
1. DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.
Powell TR; Smith RG; Hackinger S; Schalkwyk LC; Uher R; McGuffin P; Mill J; Tansey KE
Transl Psychiatry; 2013 Sep; 3(9):e300. PubMed ID: 24002086
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P
Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315
[TBL] [Abstract][Full Text] [Related]
3. HTR1A/1B DNA methylation may predict escitalopram treatment response in depressed Chinese Han patients.
Wang P; Lv Q; Mao Y; Zhang C; Bao C; Sun H; Chen H; Yi Z; Cai W; Fang Y
J Affect Disord; 2018 Mar; 228():222-228. PubMed ID: 29275155
[TBL] [Abstract][Full Text] [Related]
4. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.
Ju C; Fiori LM; Belzeaux R; Theroux JF; Chen GG; Aouabed Z; Blier P; Farzan F; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Milev R; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Uher R; Li Q; Foster JA; Kennedy SH; Turecki G
Transl Psychiatry; 2019 Oct; 9(1):254. PubMed ID: 31594917
[TBL] [Abstract][Full Text] [Related]
5. Non-random dropout and the relative efficacy of escitalopram and nortriptyline in treating major depressive disorder.
Power RA; Muthén B; Henigsberg N; Mors O; Placentino A; Mendlewicz J; Maier W; McGuffin P; Lewis CM; Uher R
J Psychiatr Res; 2012 Oct; 46(10):1333-8. PubMed ID: 22770672
[TBL] [Abstract][Full Text] [Related]
6. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
[TBL] [Abstract][Full Text] [Related]
7. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
[TBL] [Abstract][Full Text] [Related]
8. Association of DNA methylation in BDNF with escitalopram treatment response in depressed Chinese Han patients.
Wang P; Zhang C; Lv Q; Bao C; Sun H; Ma G; Fang Y; Yi Z; Cai W
Eur J Clin Pharmacol; 2018 Aug; 74(8):1011-1020. PubMed ID: 29748862
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant effects of nortriptyline and escitalopram in the GENDEP study: is one better than the other?
Uher R; Mors O; McGuffin P
Acta Psychiatr Scand; 2013 Apr; 127(4):330. PubMed ID: 23480387
[No Abstract] [Full Text] [Related]
10. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
[TBL] [Abstract][Full Text] [Related]
11. Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.
Dunlop BW; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
J Affect Disord; 2018 Mar; 229():111-119. PubMed ID: 29306690
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation and clinical response to antidepressant medication in major depressive disorder: A review and recommendations.
Lisoway AJ; Zai CC; Tiwari AK; Kennedy JL
Neurosci Lett; 2018 Mar; 669():14-23. PubMed ID: 28063933
[TBL] [Abstract][Full Text] [Related]
13. Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
Köhler-Forsberg O; Larsen ER; Buttenschøn HN; Rietschel M; Hauser J; Souery D; Maier W; Farmer A; McGuffin P; Aitchison KJ; Uher R; Mors O
Br J Psychiatry; 2019 Aug; 215(2):494-501. PubMed ID: 30698114
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomics and the mechanisms of antidepressant efficacy.
Hodgson K; Tansey KE; Powell TR; Coppola G; Uher R; Zvezdana Dernovšek M; Mors O; Hauser J; Souery D; Maier W; Henigsberg N; Rietschel M; Placentino A; Aitchison KJ; Craig IW; Farmer AE; Breen G; McGuffin P; Dobson R
Eur Neuropsychopharmacol; 2016 Jan; 26(1):105-112. PubMed ID: 26621261
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response.
Domschke K; Tidow N; Schwarte K; Deckert J; Lesch KP; Arolt V; Zwanzger P; Baune BT
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1167-76. PubMed ID: 24679990
[TBL] [Abstract][Full Text] [Related]
16. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
Perroud N; Aitchison KJ; Uher R; Smith R; Huezo-Diaz P; Marusic A; Maier W; Mors O; Placentino A; Henigsberg N; Rietschel M; Hauser J; Souery D; Kapelski P; Bonvicini C; Zobel A; Jorgensen L; Petrovic A; Kalember P; Schulze TG; Gupta B; Gray J; Lewis CM; Farmer AE; McGuffin P; Craig I
Neuropsychopharmacology; 2009 Nov; 34(12):2517-28. PubMed ID: 19641488
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response.
Powell TR; Schalkwyk LC; Heffernan AL; Breen G; Lawrence T; Price T; Farmer AE; Aitchison KJ; Craig IW; Danese A; Lewis C; McGuffin P; Uher R; Tansey KE; D'Souza UM
Eur Neuropsychopharmacol; 2013 Sep; 23(9):1105-14. PubMed ID: 23142150
[TBL] [Abstract][Full Text] [Related]
18. Variation in GNB3 predicts response and adverse reactions to antidepressants.
Keers R; Bonvicini C; Scassellati C; Uher R; Placentino A; Giovannini C; Rietschel M; Henigsberg N; Kozel D; Mors O; Maier W; Hauser J; Souery D; Mendlewicz J; Schmäl C; Zobel A; Larsen ER; Szczepankiewicz A; Kovacic Z; Elkin A; Craig I; McGuffin P; Farmer AE; Aitchison KJ; Gennarelli M
J Psychopharmacol; 2011 Jul; 25(7):867-74. PubMed ID: 20826553
[TBL] [Abstract][Full Text] [Related]
19. The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review.
Webb LM; Phillips KE; Ho MC; Veldic M; Blacker CJ
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012861
[TBL] [Abstract][Full Text] [Related]
20. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms.
Uher R; Perlis RH; Henigsberg N; Zobel A; Rietschel M; Mors O; Hauser J; Dernovsek MZ; Souery D; Bajs M; Maier W; Aitchison KJ; Farmer A; McGuffin P
Psychol Med; 2012 May; 42(5):967-80. PubMed ID: 21929846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
